Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market by Service Type (In-house, Contract Outsourcing) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global veterinary active pharmaceutical ingredient manufacturing market was valued at USD 6.9 billion in 2020. It is projected to grow at a compound annual rate (CAGR of 6.9%) between 2021 and 2028. This market is driven primarily by increasing pet spending, increased veterinarian visits, and high rates of zoonotic disease. Market growth is also a factor. The U.S. Department of Agriculture reports that there were 32.1 million beef cattle and 103.0million cattle in the U.S. as of July 2020. This number is expected to rise significantly in the future. Market growth is expected to be boosted by factors like R&D investments, improvements in procedures, high pet adoption rate, increased meat consumption, and mandatory vaccination.

The demand for veterinary Active Pharmaceutical Ingredients (APIs) is increasing due to the growing number of oral formulations for various drugs. These include mainly nonsteroidal anti-inflammatory medications. Process synthesis is a method of accelerating the production process for active pharmaceutical components. Market growth will also be supported by the introduction of bio-synthesised and high potency APIs that act on target cells at a lower dose than the general APIs.

Market players continue to strive for higher profit margins by expanding geographically. Ofichem Group, for example, opened a new office in Hangzhou in China in November 2020. This was a key part of the company's growth strategy. Zoetis' Kalamazoo manufacturing and supply plant was expanded in May 2018 to offer high-quality medicine for veterinarians and livestock farmers.

Favorable government policies have boosted the production of veterinary active pharmaceutical components. Initiatives such as Pharma Vision 2020, which is an Indian government initiative that aims to improve the country's capabilities and in drug discovery, innovation and manufacturing, are expected to have a positive effect on the political situation of the market. This will fuel market growth.

Service Type Insights

Due to its associated benefits, contract outsourcing services accounted for 58% of the total revenue in 2020. Companies are increasingly outsourcing their manufacturing and raw material procurement. This service is also becoming more popular due to the lack of captive production capacity for small and mid-sized pharmaceutical companies.

As this type of service allows for complete control over the treatment process and intellectual property, it is expected to see the fastest CAGR. This type of service is particularly popular with early-stage companies that have innovative manufacturing processes or therapies developed in the laboratory by founders or research staff.

Synthesis Type Insights

With a 39% revenue share in 2020, the chemical-based API segment was dominant in global veterinary API manufacturing. Many major manufacturers use these APIs, which can be explained by their high usage. Lonza also stated that around 70% to 80% of drugs on the market are chemical-based. Chemical-based APIs are also more cost-effective than biological APIs, which drives this segment.

From 2021 to 2028, the HPAPI segment will experience the fastest CAGR. The dosage rate for high-potency APIs is 20 to 50 percent lower than that of standard APIs. This increases their demand. The segment is expected to be driven by favorable government regulations that encourage R&D and the commercialization of novel drug molecules. Their ability to target specific diseases will increase their demand.

Product Insights

In 2020, vaccines accounted for the largest market share at over 23%. This segment will continue to grow at a substantial CAGR between 2021 and 2028. This is due to the growing demand for vaccinations because of the high incidence of chronic diseases in animals. The segment is expected to grow due to the increasing number of animals and animal husbandry, as well as the increased demand for vaccines.

The fastest-growing segment in the forecast period is expected to be NSAIDs. Anti-infectives products will be the second-highest revenue segment by 2028, due to rising incidences of infection in animals. The CDC reported that 66% of 10 infectious diseases among humans were transmitted by animals in July 2017. This has led to a lot of pressure on pharmaceutical companies to create anti-infective APIs.

Regional Insights

North America was the largest regional market in 2020, accounting for 31% of all revenue. Zoonoses pose a threat to public health because animals can be the source of disease. Market growth is largely due to the high incidence of zoonotic disease. Favorable reimbursement programs fuel the demand for veterinarian medicine and provide a platform for growth for this market.

Asia Pacific, on the other hand is expected to be the fastest growing regional market between 2021 and 2028. The region's high cattle population has fueled the need for meat production. This is why the market is growing. China and India account for more than 30% of global cattle populations. In 2018, Asia Pacific produced 40 to 50% of all global meat production.

Market Share Insights & Key Companies

To maintain market dominance, major companies are now focusing on strategic initiatives such as acquisitions and mergers. Alivira Animal Health Ltd. purchased Provet Veteriner Urunleri San in November 2020. Ve Tic. A. S. in Turkey This increased the company's geographic footprint and expanded its product range. SUANFARMA purchased an Italian API manufacturing plant called Sandoz Industrial Products SpA in October 2019. This acquisition increased the company's production and supported its global expansion strategy. These are some of the major players in the global veterinary API manufacturing industry:

• Alivira Animal Health Ltd.

• Excel Industries Ltd.

• Ofichem Group

• Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.

• Menadiona

• Afton Pharmacy

• Jiangsu Lingyun Pharmaceutical Co., Ltd.

• SUANFARMA

• NGL Fine-Chem Ltd.

• FIS - Fabbrica Italiana Sintetici S.p.A

Up Market Research published a new report titled “Veterinary Active Pharmaceutical Ingredients Manufacturing Market research report which is segmented by Service Type (In-house, Contract Outsourcing), By Players/Companies Adani Pharmachem Private Limited, SuanFarma, Oceanic Pharmachem Pvt Ltd, Century Pharmaceuticals Ltd, Chempro Pharma Private Limited, Menadiona, Uquifa, MPI Pharmazeutika GmbH, VetPharma (Part of Chemo), Siflon, Alivira Animal Health Limited, Alchemy Impex, Excel Industries Ltd”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Segments:

The market is segmented by Service Type (In-house, Contract Outsourcing).

Veterinary Active Pharmaceutical Ingredients Manufacturing Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market

Overview of the regional outlook of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Veterinary Active Pharmaceutical Ingredients Manufacturing Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. In-house

                2. Contract Outsourcing

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Veterinary Active Pharmaceutical Ingredients Manufacturing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.